Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Overview
Date Founded

1960

Headquarters

81 Wyman Street Waltham, Massachusetts, 02454, United States

Type of Company

Public

Employees (Worldwide)

70K

Industries

Industrial Machinery & Manufacturing
Wholesale: Industrial Products & Manufacturing
Medical Products & Equipment
Hospitals & Patient Services
Computer Software
Biotechnology

Company Description

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Contact Data
Trying to get in touch with decision makers at Thermo Fisher Scientific, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Senior Vice President & General Counsel

Senior Vice President & Chief Information Officer

Chief Scientific Officer

Chief Accounting Officer

Chief Human Resources Officer & Senior Vice President

Vice President & General Manager

Senior Vice President & President, Customer Channels

Board of Directors

President & Chief Executive Officer at Thermo Fisher Scientific, Inc.

Chief Financial Officer at Uber Technologies, Inc.

Co-President at Thomas H. Lee Partners LP

Former Executive Vice President & Chief Financial Officer at Merck & Co., Inc.

Former President & Chief Executive Officer at Novo Nordisk A/S

Chairman & Chief Executive Officer at Deutsch Engineered Connecting Devices Corp.

Chief Business Officer at University of Texas at Austin - Dell Medical School

Founder at Dragonfly Therapeutics, Inc.

Advisor at Xfund Management Co. LLC

Chief Executive Officer at DPx Holdings BV

Paths to Thermo Fisher Scientific, Inc.
Potential Connections via
Relationship Science
You
Thermo Fisher Scientific, Inc.
Owners & Shareholders
Details Hidden

Price Associates' investment approach is based on the belief that fundamental proprietary research drives value-added, active investment management. The firm maintains a global research platform that includes interconnected teams of research analysts. Their strategy begins with bottom-up analysis. Price Associates uses both qualitative and quantitative analysis to evaluate investment opportunities. Portfolios are created with a commitment to diversification and a strict attention to valuation appropriate to the chosen investment universe. The firm focuses its analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer. Price Associates' Private Asset management Group provides balanced, equity and fixed-income investment management services to meet the needs of individuals, trusts, endowments, foundations, institutions, retirement plans and IRAs and other entities.

Details Hidden

MFS Investment Management utilizes various investment techniques to implement its investment strategies, including, but not limited to, long and short-term purchases, short sales, margin transactions, options, and exchange-traded and over-the-counter derivatives or other methods to seek to achieve performance. They employ a variety of methods to evaluate securities, including fundamental and quantitative analysis. MFS Investment Management offers fundamental, active and research-driven equity strategies that strive for less volatility relative to benchmarks and greater value through changing markets. Fixed income strategy offers total return focused and credit oriented approach. Multi-Asset strategy is goal-oriented, diversified and disciplined investment approach that combines broad diversification across multiple asset classes, active asset allocation, and bottom-up security selection. MFS' retirement solutions are designed with a goal of maximizing growth and supporting income over a lifetime by focusing on long-term returns. MFS Blended Research is an approach to active equity management that combines the firm's fundamental research expertise with highly systematic quantitative research.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm is committed to maintaining low operating expenses, among the lowest in the fund industry. They utilize fundamental research to gather in-depth information on markets and companies around the world. CWI employs a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases GlaxoSmithKline Plc /Cork Site from GlaxoSmithKline Plc

Details Hidden

Thermo Fisher Scientific, Inc. purchases Brammer Bio LLC from Ampersand Management LLC

Details Hidden

Thermo Fisher Scientific, Inc. purchases IntegenX, Inc. from Latterell Venture Partners, Questmark Management Co. LLC, Domain Associates LLC, Greenspring Associates, Inc., Essex Woodlands Management, Inc., Amidzad LLC, Cross Creek Advisors LLC, Samsung Ventures America, Hercules Capital, In-Q-Tel, Plug & Play Venture Group LLC

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onKohlberg Kravis Roberts & Co. LP, PHC Holdings Corp. purchase from Thermo Fisher Scientific, Inc. resulting in a new company Epredia

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Advisors & Consultants
Legal Advisor

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Legal Advisor

Partner at Covington & Burling LLP

Advisor

President at Shaker Recruitment Advertising & Communications, Inc.

Clients

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Key Stats and Financials As of 2018
Market Capitalization
$117B
Total Enterprise Value
$108B
Earnings Per Share
$7.24
Revenue
$24.4B
Net Profit
$2.94B
EBITDA
$6.14B
EBITDAMargin
25.2%
Total Debt
$19B
Total Equity
$27.6B
Enterprise Value Sales
4.42x
Enterprise Value EBITDAOperating
17.55x
TEVNet Income
36.67x
Debt TEV
0.18x
Three Year Compounded Annual Growth Rate Of Revenue
12.81%
Five Year Compounded Annual Growth Rate Of Revenue
13.22%
Non-Profit Donations & Grants
$5,000 - $10K
2012
Non-Profit Donations & Grants Received
Investments
Details Hidden

EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California.

Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Venture Partner at LaunchCapital LLC

Suppliers
Luminex Corp. Medical Support Services | Austin, TX

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Deutsche Post AG Other Business & Consulting Services | Bonn, NW

The Deutsche Post and DHL corporate brands offer a one-of-a-kind portfolio of logistics and communications services. The Group provides its customers with both easy to use standardized products as well as innovative and tailored solutions ranging from dialog marketing to industrial supply chains. About 475,000 employees in more than 220 countries and territories form a global network focused on service, quality and sustainability. With programs in the areas of climate protection, disaster relief and education, the Group is committed to social responsibility.

Response Biomedical Corp. Other Business & Consulting Services | Vancouver, BC

Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded by William Joseph Radvak on August 20, 1980 and is headquartered in Vancouver, Canada.

Awards & Honors
Rank #164
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #164
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thermo Fisher Scientific, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thermo Fisher Scientific, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Thermo Fisher Scientific, Inc..